-
JC-1 Assays for Mitochondrial Membrane Potential
2026-09-22
JC-1 provides a ratiometric view of mitochondrial membrane potential, helping distinguish mitochondrial depolarization from broad changes in cell number or dye loading. This guide translates the probe into practical workflows for apoptosis detection, mitochondrial dysfunction research, and cellular bioenergetics studies, with optimization strategies for imaging and flow cytometry.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-09-22
Build reproducible translation, delivery, viability, and imaging assays with a Cap1-capped, polyadenylated firefly luciferase transcript. This guide connects practical handling and troubleshooting with affinity-capture findings relevant to full-length 1,921-nt mRNA workflows.
-
Hoechst 33342 for TNT Transport Imaging
2026-09-21
Hoechst 33342 adds a fast, live-cell nuclear reference to advanced imaging workflows, helping researchers segment cells, assess chromatin morphology, and interpret lipid-droplet transport in tunneling nanotubes. This guide connects practical staining conditions with the force-regulated multimotor transport framework reported in ACS Nano.
-
Sulfo-NHS-SS-Biotin for Surface Protein Labeling
2026-09-21
Sulfo-NHS-SS-Biotin combines membrane-impermeant surface labeling with a cleavable disulfide spacer, enabling researchers to distinguish receptor trafficking from total cellular abundance. This workflow translates the GluN2B R519Q proteostasis findings into practical surface-expression, affinity-capture, and reversible protein purification assays.
-
Leucomycin (Kitasamycin): From Ribosome to Translation
2026-09-20
Leucomycin, also known as kitasamycin, offers translational researchers a useful bridge between ribosomal mechanism, bacterial growth inhibition assay design, and resistance-informed antibacterial drug discovery. This article examines how 23S rRNA engagement, isolate-level susceptibility, and animal evidence can be integrated into a more decision-ready workflow for translational inhibition studies and macrolide resistance characterization.
-
Chlorambucil: From DNA Damage to Translational Insight
2026-09-19
A translational framework for using Chlorambucil to connect DNA crosslinking, growth inhibition, apoptosis, and reproducible cancer-response assays across CLL, glioma, and comparative models.
-
Amiloride (MK-870) Workflows for Ion Transport
2026-09-19
Amiloride (MK-870) supports controlled studies of epithelial sodium transport, PC2-associated ion movement, and uPAR-linked cellular uptake. Its value is especially strong in mechanism-mapping workflows, where a carefully timed negative result can distinguish sodium-channel effects from clathrin-dependent endocytosis.
-
Standardized Whole-Blood Stimulation and Immunometabolism
2026-09-18
Zhao and colleagues present a standardized fresh whole-blood assay that combines innate immune stimulation with pharmacological modulation of cellular metabolism. The protocol improves experimental comparability while showing that anabolic and catabolic pathway inhibitors can selectively reshape cytokine production, creating a practical platform for cohort-scale immunometabolism research.
-
ABT-888 (Veliparib): DNA Damage Response Guide
2026-09-17
ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for studying DNA repair inhibition and combination therapy. This guide goes beyond standard mechanism summaries by showing how model genetics, damage type, and assay design determine whether PARP inhibition produces meaningful sensitization.
-
GLT-1, CB1-CREB Signaling, and TBI Cognition
2026-09-17
The reference study identifies a time-dependent loss of astrocytic GLT-1 after traumatic brain injury and links it mechanistically to 2-AG-driven CB1-CREB signaling. By combining a controlled cortical impact model, AM281 pharmacology, behavioral testing, and molecular assays, the work connects glutamate clearance with neuronal apoptosis and cognitive dysfunction.
-
CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness
2026-09-17
Boyle et al. show that CCR7 and Notch1 form a functional signaling circuit that sustains stem-like behavior in MMTV-PyMT mammary cancer cells. The study supports dual pathway investigation while also clarifying that biochemical purification tools can complement, but not replace, cell-based cancer stemness assays.
-
AM 281: Reading CB1 Signaling in Brain Injury
2026-09-16
AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting how endocannabinoid signaling, GLT-1 regulation, and glutamate excitotoxicity interact after traumatic brain injury. This article focuses on assay design, temporal interpretation, and translational boundaries rather than repeating a conventional product workflow.
-
Tropisetron Hydrochloride: Assay Workflow Guide
2026-09-15
Tropisetron Hydrochloride enables controlled interrogation of 5-HT3 receptor signaling while also supporting α7-nicotinic receptor and renal transporter studies. This workflow guide shows how to separate receptor pharmacology from OCT2/MATE1 effects, select practical assay conditions, and troubleshoot solvent, timing, and interpretation issues.
-
Novobiocin Workflows for Synergy and Resistance
2026-09-15
Novobiocin combines aminocoumarin antibacterial activity with Hsp90-directed effects, making it useful for mechanism-led bacterial, antiparasitic, and antiviral workflows. This guide translates a validated synergy-testing framework into practical concentration planning, orthogonal readouts, and troubleshooting strategies.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-14
A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of ApoE−/− mouse experiments, foam-cell models, Smart-seq profiling, and macrophage-specific RXRα knockdown provides a mechanistic framework for linking nuclear-receptor activity to ubiquitin-dependent regulation of the GATA4/p62 complex.